Bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine are seen lined up during a vaccination programme in Schiedam in this November 23, 2009 file picture. To match Special Report VACCINES-NARCOLEPSY.
A nurse prepares a dose of H1N1 flu vaccine at Prince Hamzeh hospital in Amman in this November 17, 2009 file photo. To match Special Report VACCINES-NARCOLEPSY.
An Indian medical staff member treats a Swine Flu (H1N1 Influenza Virus) patients at an isolation ward of the Ahmedabad Civil Hospital in Ahmedabad on February 15, 2013. In a span of two months, some 23 people have succumbed to the virus in India's Gujarat state.
Bottles of adjuvants for use with the Pandemrix H1N1 flu vaccine are seen lined up during a vaccination programme in Schiedam in this November 23, 2009 file photo. Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny. The ingredient is one of a class of pharmaceuticals known as adjuvants, or boosters, designed to turbo charge the potency of a vaccine and the body's immune response to it. AS03 was widely used in Europe during the 2009-2010 H1N1 flu pandemic and is also contained in a GSK adjuvanted flu vaccine which in November last year became the first of its kind to be recommended for approval by the normally adjuvant-wary United States Food and Drug Administration (FDA). To match Insight NARCOLEPSY-VACCINE/ADJUVANT.
Employees of the Hamas Ministry of Agriculture collect poultry that was smuggled into the Gaza Strip from Egypt by Palestinian farm owners, on February 5, 2013 at a poultry farm in Deir al-Balah in central Gaza Strip. Hamas authorities have confiscated some 10 thousand chickens fearing the H1N1 influenza strain known as swine flu. It will take at least 10 years to eradicate the H5N1 bird flu virus, which has killed scores of humans, from poultry in the six countries where it is endemic, a UN agency said.
Director for health and social care at the Swedish Association of Local Authorities and Regions Goran Stiernstedt gestures during an interview with Reuters in Stockholm January 17, 2013. Stiernstedt has spent many difficult hours going over what happened in his country during the swine flu pandemic, wondering if things should have been different. Finland, Norway, Ireland and France have seen spikes in narcolepsy cases in around 800 children after being immunised with the Pandemrix H1N1 swine flu vaccine made by British drugmaker GlaxoSmithKline in 2009 and people familiar with the results of a soon-to-be-published study in Britain have told Reuters it will show a similar pattern in children there. Picture taken January 17, 2013. To match insight NARCOLEPSY-VACCINE/PANDEMRIX.
